Powder: -20°C for 3 years | In solvent: -80°C for 1 year
SLB1122168 is a potent inhibitor of Spns2-mediated sphingosine-1-phosphate (S1P) release, exhibiting an IC50 value of 94 nM [1].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
2 mg | 5 days | $ 130.00 |
Description | SLB1122168 is a potent inhibitor of Spns2-mediated sphingosine-1-phosphate (S1P) release, exhibiting an IC50 value of 94 nM [1]. |
In vivo | SLB1122168 (33p; 10 mg/kg; intraperitoneal injection; single dose) induced a dose-dependent reduction in circulating lymphocytes [1]. In rats, a dose of 10 mg/kg resulted in a peak concentration of 4 μM for SLB1122168 (33p) at 2 hours post-administration, with levels remaining ≥1 μM up to 24 hours and a half-life of 8 hours [1]. |
Molecular Weight | 403.56 |
Formula | C23H37N3O3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
SLB1122168 formic GPCR/G Protein LPL Receptor inhibitor inhibit